EFOI
Energy Focus, Inc.
There isn't enough reported data to score EFOI yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
EFOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Healthy | |
| Unavailable |
EFOI's revenue and cash flow are currently healthy, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
EFOI PE Valuation
EFOI has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
EFOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect EFOI's losses to grow, with revenue growing.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
EFOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.14 | +$0.03 |
| Q2 2026 | -$0.25 | -$0.05 |
| Q1 2026 | -$0.15 | +$0.13 |
| Q4 2025 | -$0.18 | +$0.14 |
| Q3 2025 | -$0.17 | +$0.65 |
| Q2 2025 | -$0.20 | +$0.83 |
| Q1 2025 | -$0.28 | +$1.05 |
| Q4 2024 | -$0.32 | +$1.48 |
EFOI is still losing money, but far less than before: $0.14 per share over the past year, against $21.35 at its worst in late 2019.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over EFOI on earnings, with more consistent year-over-year improvement.
EFOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8M | +481% |
| Q2 2026 | $3.7M | +228% |
| Q1 2026 | $949K | +54% |
| Q4 2025 | $975K | -24% |
| Q3 2025 | $826K | -31% |
| Q2 2025 | $1.1M | -26% |
| Q1 2025 | $616K | -26% |
| Q4 2024 | $1.3M | -47% |
EFOI's revenue is recovering but still below its 2020 peak: $5M last quarter, up 481% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +32 points |
| Q2 2026 | -23% | -3.5 points |
| Q1 2026 | -15% | +29 points |
| Q4 2025 | -37% | -14 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -20% | +16 points |
| Q1 2025 | -44% | +28 points |
| Q4 2024 | -23% | +9.4 points |
EFOI has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over EFOI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
EFOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.2M | +$2.3M |
| Q2 2026 | -$819K | -$604K |
| Q1 2026 | $69K | +$346K |
| Q4 2025 | -$862K | -$608K |
| Q3 2025 | -$104K | +$182K |
| Q2 2025 | -$215K | +$503K |
| Q1 2025 | -$277K | -$219K |
| Q4 2024 | -$254K | -$143K |
EFOI has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
EFOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +67K shares |
| 1 year | +14% | +784K shares |
| 3 years | +131% | +3.6M shares |
| 5 years | +963% | +5.8M shares |
| Available history | +1350% | +6M shares |
EFOI has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
EFOI Net Leverage
EFOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EFOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.4 | Neutral |
| Stochastic | 76.9 | Neutral |
EFOI's weekly RSI is 68 (neutral) and its Stochastic is 77 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
EFOI PE vs Consumer Cyclical Sector
EFOI has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
EFOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 34% above |
| 20 week MA | $3.10 | 45% above |
| 50 week MA | $2.90 | 55% above |
| 100 week MA | $2.47 | 82% above |
| 200 week MA | $2.25 | 100% above |
EFOI has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
EFOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.1 | $29.4 | +83% |
| 2021 | $29.4 | $28.1 | -4.3% |
| 2022 | $28.1 | $2.10 | -93% |
| 2023 | $2.10 | $1.51 | -28% |
| 2024 | $1.51 | $1.25 | -17% |
| 2025 | $1.25 | $2.25 | +80% |
| 2026 YTD | $2.25 | $4.50 | +100% |
EFOI has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.